Collaboratively developed and marketed by Cantel subsidiaries Medivators and Mar Cor Purification, REVOX Sterilization Solutions offers the first commercially available room temperature vapor sterilization process. With full contract validation and sterilization services as well as on-site processing potential with multiple chamber configurations, REVOX Sterilization Solutions is positioned to foster increased innovation and production efficiencies for manufacturers of advanced devices. In May 2014 a Class II implantable device was granted FDA clearance with the REVOX sterilization process. REVOX Sterilization Solutions • Gentle room temperature process (18oC – 30oC) • No harmful residuals • PAA chemistry breaks down to CO2, H20, and O2 • No lengthy pre-conditioning or post-processing aeration required • Multiple chamber configuration options for safe, efficient, on-site sterile processing • Fast turn-around contract sterilization services • Expert guidance to help meet technical, operational, and financial project objectives Specialties Sterile processing, product sterilization, low-temperature sterilization, on-site sterilization, development & validation services
View Top Employees from REVOX Sterilization SolutionsWebsite | https://www.revoxsterilization.com |
Revenue | $167 million |
Employees | 5 (3 on RocketReach) |
Founded | 2010 |
Address | 14605 28th Ave. North, Minneapolis, Minnesota 55447, US |
Phone | (855) 473-8690 |
Technologies |
JavaScript,
HTML,
Twitter
+9 more
(view full list)
|
Industry | Medical Devices, Medical Devices & Equipment, Medical Device, Security and Investigations, Manufacturing, Health Care |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
Looking for a particular REVOX Sterilization Solutions employee's phone or email?
The REVOX Sterilization Solutions annual revenue was $167 million in 2024.
3 people are employed at REVOX Sterilization Solutions.
REVOX Sterilization Solutions is based in Minneapolis, Minnesota.
The SIC codes for REVOX Sterilization Solutions are [38, 384].